These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3124801

  • 1. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.
    Rootman DS, Hobden JA, Jantzen JA, Gonzalez JR, O'Callaghan RJ, Hill JM.
    Arch Ophthalmol; 1988 Feb; 106(2):262-5. PubMed ID: 3124801
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
    Reidy JJ, Hobden JA, Hill JM, Forman K, O'Callaghan RJ.
    Cornea; 1991 Jan; 10(1):25-8. PubMed ID: 1902152
    [Abstract] [Full Text] [Related]

  • 7. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P, Riske PS, Zaya NE, Carey R, Bouchard CS.
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [Abstract] [Full Text] [Related]

  • 8. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Lauffenburger MD, Cohen KL.
    Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis.
    Assil KK, Frucht-Perry J, Ziegler E, Schanzlin DJ, Schneiderman T, Weinreb RN.
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3216-20. PubMed ID: 1748553
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
    Dajcs JJ, Moreau JM, Stroman DW, Schlech BA, Ke TL, Thibodeaux BA, Girgis DO, Caballero AR, O'Callaghan RJ.
    Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC, O'Callaghan RJ, Hill JM.
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.